Predictors and outcomes of healthcare-associated infections in COVID-19 patients

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

(2020) Nanshan Chen et al.   LANCET

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

(2020) Eva Schrezenmeier et al.   Nature Reviews Rheumatology

Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy

(2020) Valentina Morena et al.   European Journal of Internal Medicine

A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease‐19 (COVID‐19)

(2020) Sanket Shah et al.   International Journal of Rheumatic Diseases

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

(2020) Joshua Geleris et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

(2020) Wei Tang et al.   BMJ-British Medical Journal

Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia

(2020) Stanley C Jordan et al.   CLINICAL INFECTIOUS DISEASES

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

(2020) W. Joost Wiersinga et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis

(2020) Roberto Rossotti et al.   JOURNAL OF INFECTION

Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study

(2019) Ajinkya Pawar et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0

(2018) Renyu Ding et al.   BLOOD COAGULATION & FIBRINOLYSIS

The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09

(2018) Chandini Raina MacIntyre et al.   BMC INFECTIOUS DISEASES

Culture-Negative Severe Sepsis

(2016) Shipra Gupta et al.   CHEST

Macrophage activation syndrome in the era of biologic therapy

(2016) Alexei A. Grom et al.   Nature Reviews Rheumatology

Incidence, risk factors and impact on outcomes of secondary infection in patients with septic shock: an 8-year retrospective study

(2016) Guang-ju Zhao et al.   Scientific Reports

Virus-induced secondary bacterial infection: a concise review

(2015) Mohamed Hendaus et al.   Therapeutics and Clinical Risk Management

Epidemiology and clinical characteristics of hospitalized patients with pandemic influenza A (H1N1) 2009 infections: the effects of bacterial coinfection

(2011) Amreeta Dhanoa et al.   Virology Journal

Influenza Virus Infection Decreases Tracheal Mucociliary Velocity and Clearance ofStreptococcus pneumoniae

(2009) Lynnelle A. Pittet et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL

Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness

(2008) David M. Morens et al.   JOURNAL OF INFECTIOUS DISEASES